brieka hart hylki 25 mg
teva b.v.* - pregabalinum inn - hart hylki - 25 mg
finól (finol) filmuhúðuð tafla 5 mg
actavis group ptc ehf. - finasteridum inn - filmuhúðuð tafla - 5 mg
pregabalin krka hart hylki 100 mg
krka, d.d., novo mesto - pregabalinum inn - hart hylki - 100 mg
pregabalin krka hart hylki 150 mg
krka, d.d., novo mesto - pregabalinum inn - hart hylki - 150 mg
pregabalin krka hart hylki 25 mg
krka, d.d., novo mesto - pregabalinum inn - hart hylki - 25 mg
pregabalin krka hart hylki 50 mg
krka, d.d., novo mesto - pregabalinum inn - hart hylki - 50 mg
pregabalin krka hart hylki 75 mg
krka, d.d., novo mesto - pregabalinum inn - hart hylki - 75 mg
pregabalin medical valley hart hylki 300 mg
medical valley invest ab - pregabalinum inn - hart hylki - 300 mg
remifentanil hameln stofn fyrir stungulyfs-/innrennslisþykkni, lausn 2 mg
hameln pharma gmbh - remifentanilum hýdróklóríð - stofn fyrir stungulyfs-/innrennslisþykkni, lausn - 2 mg
sitagliptin / metformin hydrochloride sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - sykursýki, tegund 2 - lyf notuð við sykursýki - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , þrefaldur samsetning meðferð) sem viðbót til að fæði og æfing í sjúklingar ekki nægilega stjórn á eigin hámarks þolað skammt af sjúklingar og sulphonylurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.